康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09966 康宁杰瑞制药-B

交易中 05-06 11:13:19

7.920

+0.070

+0.89%

最高8.200	最低7.800	成交量226.90万
今开8.000	昨收7.850	日振幅5.10%
总市值76.19亿	流通市值76.19亿	总股本9.62亿
成交额1,820万	换手率0.24%	流通股本9.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"康宁杰瑞制药-B","latestPrice":7.92,"timestamp":1746501190693,"preClose":7.85,"halted":0,"volume":2269002,"delay":0,"floatShares":961999999,"shares":961999999,"eps":0.18536744789365578,"marketStatus":"交易中","change":0.07,"latestTime":"05-06 11:13:19","open":8,"high":8.2,"low":7.8,"amount":18202876,"amplitude":0.050955,"askPrice":7.94,"askSize":2000,"bidPrice":7.91,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.18229523698794717,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1746504000000},"marketStatusCode":2,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":7.85,"openAndCloseTimeList":[[1746495000000,1746504000000],[1746507600000,1746518400000]],"volumeRatio":2.212694,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09966/wiki","defaultTab":"wiki","newsList":[{"id":"2532868367","title":"康宁杰瑞制药-B股价涨超20% 因临床试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2532868367","media":"iDoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532868367?lang=zh_cn&edition=full","pubTime":"2025-05-02 11:15","pubTimestamp":1746155701,"startTime":"0","endTime":"0","summary":"5月2日，康宁杰瑞制药-B股价上涨超过20%。此次上涨得益于其KN026关键性II/III期临床试验期中分析达到PFS主要终点，显示出良好的治疗潜力。这一进展有望推动公司新药研发进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050211153694ea6667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050211153694ea6667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","09966","BK1141","BK1576","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2532508138","title":"康宁杰瑞制药-B涨超20% 因临床试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2532508138","media":"DoNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532508138?lang=zh_cn&edition=full","pubTime":"2025-05-02 10:59","pubTimestamp":1746154741,"startTime":"0","endTime":"0","summary":"5月2日，康宁杰瑞制药-B股价涨超20%。据悉，其KN026关键性II/III期临床试验期中分析达到PFS主要终点，这一进展显著推动了市场对其前景的信心，从而带动股价上涨。此成果或将进一步加速该药物的研发进程。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502110032974d06b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502110032974d06b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","03347","BK1576","BK1161","BK1141","BK1583"],"gpt_icon":0},{"id":"2532857014","title":"晶泰控股盘中异动 早盘快速跳水5.04%报4.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532857014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532857014?lang=zh_cn&edition=full","pubTime":"2025-05-02 10:00","pubTimestamp":1746151232,"startTime":"0","endTime":"0","summary":"2025年05月02日早盘10时00分，晶泰控股股票出现异动，股价急速下跌5.04%。截至发稿，该股报4.900港元/股，成交量479.125万股，换手率0.12%，振幅6.20%。资金方面，该股资金流入495.568万港元，流出1687.67万港元。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。晶泰控股股票所在的生物技术行业中，整体跌幅为1.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050210003294ea5a76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050210003294ea5a76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1574","BK1583","BK1161","06998","02105","BK1141","09966","BK1617"],"gpt_icon":0},{"id":"2532859276","title":"康宁杰瑞制药-B现涨超12% HER2双抗KN026临床研究期中分析达PFS主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2532859276","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532859276?lang=zh_cn&edition=full","pubTime":"2025-05-02 09:50","pubTimestamp":1746150600,"startTime":"0","endTime":"0","summary":"　　康宁杰瑞制药-B盘中涨超12%，截至发稿，股价上涨12.07%，现报7.24港元，成交额1319.95万港元。　　康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体KN026联合化疗二线及以上治疗HER2阳性胃癌的Ⅱ/Ⅲ期临床研究已完成首次期中分析，经独立数据监察委员会评估，达到预先设定的无进展生存期的主要终点，具有统计学显著性和临床意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-02/doc-inevctpe5151918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4195","09966","PFS","BK1574","BK1161","BK4211"],"gpt_icon":0},{"id":"2532856051","title":"港股异动 | 康宁杰瑞制药-B(09966)涨超12% HER2双抗KN026临床研究期中分析达PFS主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2532856051","media":"智通财经","labels":["executive","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532856051?lang=zh_cn&edition=full","pubTime":"2025-05-02 09:38","pubTimestamp":1746149889,"startTime":"0","endTime":"0","summary":"消息面上，康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体KN026联合化疗二线及以上治疗HER2阳性胃癌的Ⅱ/Ⅲ期临床研究已完成首次期中分析，经独立数据监察委员会评估，达到预先设定的无进展生存期的主要终点，具有统计学显著性和临床意义。该产品国内权益已出售给石药集团，首付款与里程碑总计10 亿元，双位数销售分成。目前其临床结果十分优秀，与多西他赛联用治疗HER2 阳性BC 的PFS 为 27.7 个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09966","BK4195","BK1161","BK4211","PFS","BK1574"],"gpt_icon":0},{"id":"2532850893","title":"康宁杰瑞制药-B盘中异动 股价大涨5.73%报6.830港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532850893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532850893?lang=zh_cn&edition=full","pubTime":"2025-05-02 09:30","pubTimestamp":1746149404,"startTime":"0","endTime":"0","summary":"2025年05月02日早盘09时30分，康宁杰瑞制药-B股票出现异动，股价急速上涨5.73%。截至发稿，该股报6.830港元/股，成交量26.9万股，换手率0.03%，振幅1.70%。资金方面，该股资金流入23.8万港元，流出0港元。康宁杰瑞制药-B股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，康宁杰瑞制药-B、来凯医药-B、和铂医药-B涨幅较大，振幅较大的相关个股有来凯医药-B、和铂医药-B、康宁杰瑞制药-B，振幅分别为2.97%、1.74%、1.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050209300494ea5579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050209300494ea5579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2532701570","title":"HER2双抗KN026关键性Ⅱ/Ⅲ期临床研究期中分析达到PFS主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2532701570","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532701570?lang=zh_cn&edition=full","pubTime":"2025-05-01 09:41","pubTimestamp":1746063660,"startTime":"0","endTime":"0","summary":"苏州 2025年5月1日 /美通社/ --康宁杰瑞生物制药与石药集团共同宣布，HER2双特异性抗体KN026联合化疗二线及以上治疗HER2阳性胃癌的Ⅱ/Ⅲ期临床研究已完成首次期中分析，经独立数据监察委员会评估，达到预先设定的无进展生存期的主要终点，具有统计学显著性和临床意义。目前针对二线及以上HER2阳性胃癌/胃食管结合部癌、一线HER2阳性乳腺癌、HER2阳性乳腺癌新辅助等适应症的多项注册临床研究正在进行中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4677725_ZH77725_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4195","BK4211","09966","BK1161","BK1574","PFS"],"gpt_icon":0},{"id":"2531035965","title":"康宁杰瑞制药-B(09966)：KN026关键性II/III期临床试验期中分析达到PFS主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2531035965","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531035965?lang=zh_cn&edition=full","pubTime":"2025-04-30 19:30","pubTimestamp":1746012652,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康宁杰瑞制药-B 发布公告，本公司与石药集团有限公司附属公司上海津曼特生物科技有限公司合作开发的KN026联合化疗二线及以上治疗HER2阳性GC的II/III期临床试验已完成首个期中分析及期中分析结果达到PFS主要终点。KN026-001研究第2部分的首个PFS期中分析结果已由独立数据监察委员会 审查，结果显示达到预先设定的PFS的主要终点，具有统计学显著性和临床意义。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4195","BK1141","PFS","BK1574","BK4211","BK1583","BK1161","BK1576","III","BK4134","09966","03347"],"gpt_icon":0},{"id":"2531081843","title":"每日卖空追踪 | 康宁杰瑞制药-B 04月30日卖空量成交2000股，卖空比例为0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531081843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531081843?lang=zh_cn&edition=full","pubTime":"2025-04-30 17:49","pubTimestamp":1746006579,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间04月30日，跌3.58%，卖空量成交2000股，较上一交易日减少90.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430175913a6ceaa26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430175913a6ceaa26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2531503416","title":"康宁杰瑞两项双靶点ADC临床前研究数据在2025年AACR年会公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2531503416","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531503416?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:04","pubTimestamp":1745978640,"startTime":"0","endTime":"0","summary":"苏州 2025年4月30日 /美通社/ -- 康宁杰瑞生物制药宣布，公司在2025年美国癌症研究协会年会上，以壁报形式公布了两种新型双特异性抗体偶联药物JSKN021和JSKN022的临床前研究数据。本届AACR年会于当地时间2025年4月25日至30日在美国芝加哥举办。通过精确调控双靶点结合亲和力，JSKN021在有效应对肿瘤异质性的同时最大限度降低非肿瘤靶向毒性。此外，公司有多个双抗和双抗ADC项目在临床研究阶段，并且快速推进以双抗ADC和双载荷ADC为主的临床前管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4676413_ZH76413_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ADC","LU0348723411.USD","BK4080","BK1574","BK4512","BK1161","BK4231","BK4585","GLW","BK4588","BK4148","IE00BFMHRM44.USD","09966"],"gpt_icon":0},{"id":"2531748186","title":"康宁杰瑞制药-B(09966)：于2025年AACR年会呈列的JSKN021及JSKN022的最新研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2531748186","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531748186?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:13","pubTimestamp":1745972029,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B(09966)发布公告，JSKN021及JSKN022临床前研究的...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_19.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_19.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康宁杰瑞制药-B(09966)：于2025年AACR年会呈列的JSKN021及JSKN022的最新研究成果","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2531474350","title":"康宁杰瑞制药-B：于2025年AACR年会呈列的JSKN021及JSKN022的最新研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2531474350","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531474350?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:10","pubTimestamp":1745971818,"startTime":"0","endTime":"0","summary":"格隆汇4月30日丨康宁杰瑞制药-B(09966.HK)发布公告，JSKN021及JSKN022临床前研究的最新成果已于2025年4月25日至4月30日举行的2025年AACR年会(2025年美国癌症研究协会年会，美国癌症研究协会为致力于攻克癌症的成立最早、规模最大的癌症研究组织之一)的壁报展示期间(摘要展示编号：5450及5451)公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430081018a46cd9d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430081018a46cd9d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2531720164","title":"每日卖空追踪 | 康宁杰瑞制药-B 04月29日卖空量成交2.1万股，卖空比例为1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531720164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531720164?lang=zh_cn&edition=full","pubTime":"2025-04-29 16:53","pubTimestamp":1745916835,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间04月29日，跌1.76%，卖空量成交2.1万股，较上一交易日增加61.54%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429172801a46bd9a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429172801a46bd9a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09966","BK1161"],"gpt_icon":0},{"id":"2530193595","title":"每日卖空追踪 | 康宁杰瑞制药-B 04月25日卖空量成交17.2万股，卖空比例为5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530193595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530193595?lang=zh_cn&edition=full","pubTime":"2025-04-26 04:40","pubTimestamp":1745613657,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间04月25日，跌0.43%，卖空量成交17.2万股，较上一交易日增加230.77%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426044101a46743bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426044101a46743bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09966","BK1161"],"gpt_icon":0},{"id":"2529867950","title":"康宁杰瑞制药-B04月24日主力净流出56万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529867950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529867950?lang=zh_cn&edition=full","pubTime":"2025-04-24 16:17","pubTimestamp":1745482623,"startTime":"0","endTime":"0","summary":"04月24日, 康宁杰瑞制药-B股价跌5.19%，报收6.94元，成交金额2188万元，换手率0.32%，振幅7.38%，量比1.30。康宁杰瑞制药-B今日主力资金净流出56万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.57%，主力资金累计净流出195万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1336万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170504a6c6579f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170504a6c6579f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2529879236","title":"康宁杰瑞制药-B授出5万份购股权及49万股奖励股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879236","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529879236?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:58","pubTimestamp":1745416690,"startTime":"0","endTime":"0","summary":"格隆汇4月23日丨康宁杰瑞制药-B(09966.HK)公告，于2025年4月23日，根据首次公开发售后购股权计划，公司已决议向两名合资格参与者(\"购股权承授人\")(即集团的雇员)授出购股权，以认购最多合共5万股公司股本中每股面值0.000002美元公司普通股，惟须待购股权承授人接纳后，方可作实。根据限制性股份奖励计划，公司已决议向五名合资格参与者(\"奖励承授人\")(即集团的雇员)授出合共49万股奖励股份，惟须待奖励承授人接纳后，方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321582697423ab7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321582697423ab7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2529924945","title":"康宁杰瑞制药-B盘中异动 早盘股价大涨5.03%报7.310港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529924945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529924945?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:31","pubTimestamp":1745371864,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘09时31分，康宁杰瑞制药-B股票出现波动，股价大幅拉升5.03%。截至发稿，该股报7.310港元/股，成交量12.3万股，换手率0.01%，振幅4.60%。资金方面，该股资金流入62.512万港元，流出4.32万港元。康宁杰瑞制药-B股票所在的生物技术行业中，整体涨幅为2.89%。康宁杰瑞制药-B公司简介：康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093104a463303f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093104a463303f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09966"],"gpt_icon":0},{"id":"2529524665","title":"每日卖空追踪 | 康宁杰瑞制药-B 04月22日卖空量成交12.8万股，卖空比例为3.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529524665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529524665?lang=zh_cn&edition=full","pubTime":"2025-04-23 04:21","pubTimestamp":1745353261,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间04月22日，涨4.98%，卖空量成交12.8万股，较上一交易日减少27.27%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423042105a462e64e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423042105a462e64e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2529315153","title":"康宁杰瑞制药-B盘中异动 下午盘大幅上涨5.13%报6.970港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529315153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529315153?lang=zh_cn&edition=full","pubTime":"2025-04-22 13:08","pubTimestamp":1745298535,"startTime":"0","endTime":"0","summary":"2025年04月22日下午盘13时08分，康宁杰瑞制药-B股票出现异动，股价大幅拉升5.13%。截至发稿，该股报6.970港元/股，成交量173.642万股，换手率0.18%，振幅6.49%。资金方面，该股资金流入449.36万港元，流出660.9万港元。康宁杰瑞制药-B股票所在的生物技术行业中，整体涨幅为4.59%。康宁杰瑞制药-B公司简介：康宁杰瑞生物制药是一家主要从事肿瘤生物制剂研发、制造及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422130856aa2c759a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422130856aa2c759a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2528313775","title":"每日卖空追踪 | 康宁杰瑞制药-B 04月17日卖空量成交17.6万股，卖空比例为11.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528313775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528313775?lang=zh_cn&edition=full","pubTime":"2025-04-18 04:14","pubTimestamp":1744920864,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B北京时间04月17日，涨1.07%，卖空量成交17.6万股，较上一交易日增加5.39%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418041433a6be6551&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418041433a6be6551&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09966"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphamab.com","stockEarnings":[{"period":"1week","weight":0.136},{"period":"1month","weight":-0.0542},{"period":"3month","weight":1.4228},{"period":"6month","weight":1.139},{"period":"1year","weight":0.501},{"period":"ytd","weight":1.2429}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":-0.0301},{"period":"3month","weight":0.1127},{"period":"6month","weight":0.0974},{"period":"1year","weight":0.236},{"period":"ytd","weight":0.1219}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康宁杰瑞生物制药是一家投资控股公司，主要从事生物制药业务。公司专注于研发、生产和商业化创新肿瘤免疫生物大分子靶向药物的全产业链企业。公司拥有生物创新药开发技术平台，包括蛋白质工程平台、多功能抗体开发平台和抗体筛选平台。该公司在海内外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.121729},{"month":2,"riseRate":0.666667,"avgChangeRate":0.22886},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.028638},{"month":4,"riseRate":0.833333,"avgChangeRate":0.061128},{"month":5,"riseRate":0.5,"avgChangeRate":-0.044722},{"month":6,"riseRate":0.4,"avgChangeRate":0.026634},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0532},{"month":8,"riseRate":0.4,"avgChangeRate":0.041129},{"month":9,"riseRate":0.2,"avgChangeRate":0.094086},{"month":10,"riseRate":0.4,"avgChangeRate":-0.004359},{"month":11,"riseRate":0.6,"avgChangeRate":0.064609},{"month":12,"riseRate":0.6,"avgChangeRate":-0.004095}],"exchange":"SEHK","name":"康宁杰瑞制药-B","nameEN":"ALPHAMAB-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁杰瑞制药-B,09966,康宁杰瑞制药-B股票,康宁杰瑞制药-B股票老虎,康宁杰瑞制药-B股票老虎国际,康宁杰瑞制药-B行情,康宁杰瑞制药-B股票行情,康宁杰瑞制药-B股价,康宁杰瑞制药-B股市,康宁杰瑞制药-B股票价格,康宁杰瑞制药-B股票交易,康宁杰瑞制药-B股票购买,康宁杰瑞制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁杰瑞制药-B(09966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁杰瑞制药-B(09966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}